Compare with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs TORRENT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES TORRENT PHARMA ALKEM LABORATORIES/
TORRENT PHARMA
 
P/E (TTM) x 23.9 42.7 56.0% View Chart
P/BV x 5.7 9.3 61.2% View Chart
Dividend Yield % 0.9 1.1 78.3%  

Financials

 ALKEM LABORATORIES   TORRENT PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-21
TORRENT PHARMA
Mar-21
ALKEM LABORATORIES/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs3,1503,040 103.6%   
Low Rs2,2241,933 115.0%   
Sales per share (Unadj.) Rs741.4473.0 156.7%  
Earnings per share (Unadj.) Rs135.374.0 182.9%  
Cash flow per share (Unadj.) Rs158.3112.9 140.2%  
Dividends per share (Unadj.) Rs30.0035.00 85.7%  
Avg Dividend yield %1.11.4 79.3%  
Book value per share (Unadj.) Rs616.8344.9 178.8%  
Shares outstanding (eoy) m119.57169.22 70.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.65.3 68.9%   
Avg P/E ratio x19.933.6 59.1%  
P/CF ratio (eoy) x17.022.0 77.0%  
Price / Book Value ratio x4.47.2 60.4%  
Dividend payout %22.247.3 46.9%   
Avg Mkt Cap Rs m321,244420,798 76.3%   
No. of employees `000NANA-   
Total wages/salary Rs m16,21014,396 112.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m88,65080,048 110.7%  
Other income Rs m2,332757 307.9%   
Total revenues Rs m90,98280,806 112.6%   
Gross profit Rs m19,42424,666 78.7%  
Depreciation Rs m2,7466,578 41.7%   
Interest Rs m5893,583 16.4%   
Profit before tax Rs m18,42115,263 120.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2432,744 81.8%   
Profit after tax Rs m16,17812,519 129.2%  
Gross profit margin %21.930.8 71.1%  
Effective tax rate %12.218.0 67.7%   
Net profit margin %18.215.6 116.7%  
BALANCE SHEET DATA
Current assets Rs m69,28855,232 125.4%   
Current liabilities Rs m36,04148,916 73.7%   
Net working cap to sales %37.57.9 475.3%  
Current ratio x1.91.1 170.3%  
Inventory Days Days2014 136.3%  
Debtors Days Days667 952.7%  
Net fixed assets Rs m34,82581,298 42.8%   
Share capital Rs m239846 28.3%   
"Free" reserves Rs m73,51757,526 127.8%   
Net worth Rs m73,75658,372 126.4%   
Long term debt Rs m34329,633 1.2%   
Total assets Rs m104,114136,530 76.3%  
Interest coverage x32.35.3 613.4%   
Debt to equity ratio x00.5 0.9%  
Sales to assets ratio x0.90.6 145.2%   
Return on assets %16.111.8 136.6%  
Return on equity %21.921.4 102.3%  
Return on capital %25.721.4 119.8%  
Exports to sales %22.10-   
Imports to sales %00-   
Exports (fob) Rs m19,555NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,55521,539 90.8%   
Fx outflow Rs m2,4677,136 34.6%   
Net fx Rs m17,08814,403 118.6%   
CASH FLOW
From Operations Rs m12,64920,107 62.9%  
From Investments Rs m-9,985-4,494 222.2%  
From Financial Activity Rs m-2,718-16,561 16.4%  
Net Cashflow Rs m-17-893 1.9%  

Share Holding

Indian Promoters % 58.8 71.3 82.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 19.3 20.6 93.9%  
FIIs % 5.3 11.6 45.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 41.2 28.8 143.2%  
Shareholders   87,392 67,205 130.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex Plunges 656 Points, Nifty Ends Below 18,000; Oil & Gas, Metal Stocks Outperform(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views on News

ALKEM LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.5% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, ALKEM LABORATORIES has posted a net profit of Rs 5 bn (up 13.5% YoY). Sales on the other hand came in at Rs 27 bn (up 37.1% YoY). Read on for a complete analysis of ALKEM LABORATORIES's quarterly results.

ALKEM LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of ALKEM LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ALKEM LABORATORIES. Also includes updates on the valuation of ALKEM LABORATORIES.

Torrent Pharma Beats Expectations: Stock Gets a Boost (Views On News)

May 19, 2021

Key takeaways from Torrent Pharma's March quarter results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 19, 2022 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS